Skip to content

Vericel VCEL Other operating expenses

Other operating expenses at other companies

LeMaitre Vascular logo
LeMaitre VascularLMAT
$30.62M+6.3%
Capricor Therapeutics logo
Capricor TherapeuticsCAPR
$36.77M+47.2%
Stryker logo
StrykerSYK

Other financials

Income statement

See full
Revenue$68.4M+30.1%
Gross profit$49.3M+35.8%
Operating income-$8.1M+37.0%
Net income-$6.3M+44.0%
EPS (diluted)-$0.12+47.8%

Balance sheet

See full
Cash & equivalents$109.3M+37.1%
Total debt$95.0M-4.6%
Total equity$356.2M+20.6%
Total assets$485.6M+14.4%

Cash flow

See full
Operating cash flow$16.4M+148%
CapEx$1.3M-91.2%
Free cash flow$15.1M+299%

Valuation

See full
Market cap$2.13B-26.8%

Profitability

See full
Gross margin74.8%+2.3pp
Operating margin5.4%+4.6pp
Net margin7.3%+6.1pp
FCF margin16.3%

Returns & leverage

See full
Return on equity6.6%+5.5pp
Debt / equity0.3×-0.1×
Current ratio5.2×+0.2×

Where this comes from

Reported directly by Vericel in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The official record: Vericel’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vericel's other operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vericel's other operating expenses?
Vericel (VCEL) reported other operating expenses of $57.33M in Q1 2026.
How has Vericel's other operating expenses changed year-over-year?
Vericel's other operating expenses increased by 16.8% year-over-year, from $49.07M to $57.33M.
What is the long-term trend for Vericel's other operating expenses?
Over 4 years (2021 to 2025), Vericel's other operating expenses has grown at a 14.3% compound annual growth rate (CAGR), from $113.88M to $194.56M.
What does other operating expenses mean?
Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.